The impact of COVID on bacterial sepsis.
Sophia DarDaniel EricksonClaudia MancaTara LozyElena ShashkinaMilena KordalewskaJose R MediavillaLiang ChenAlbert RojtmanBarry N KreiswirthPublished in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
Concurrent COVID-19 infection is associated with a significant increase in morbidity and mortality in patients with GP and GN BSIs. Patients with S. aureus BSIs with COVID-19 are more likely to develop shock and respiratory failure and have higher rates and odds of mortality than those without COVID-19. These findings provide an essential insight into the care of these patients, especially those co-infected with Staphylococcus aureus.
Keyphrases
- coronavirus disease
- sars cov
- respiratory failure
- staphylococcus aureus
- end stage renal disease
- ejection fraction
- healthcare
- newly diagnosed
- extracorporeal membrane oxygenation
- intensive care unit
- mechanical ventilation
- respiratory syndrome coronavirus
- peritoneal dialysis
- palliative care
- cardiovascular events
- prognostic factors
- acute kidney injury
- squamous cell carcinoma
- type diabetes
- pain management
- radiation therapy
- coronary artery disease
- cardiovascular disease
- cystic fibrosis
- chronic pain